Vascular Biogenics Ltd. operating as VBL Therapeutics
11 clinical trials · Sponsor
◉ Watch Vascular Biogenics Ltd. operating as VBL Therapeutics
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19 (NCT04733833) | Vascular Biogenics Ltd. operating as VBL Therapeutics | 2021-01-26 |
| A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) (NCT03398655) | Vascular Biogenics Ltd. operating as VBL Therapeutics | 2017-12-19 |
Track Vascular Biogenics Ltd. operating as VBL Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.